NTLA
Intellia Therapeutics, Inc. · Healthcare
Director Muna Bhanji sold $73K of Intellia Therapeutics, Inc.
Sold$73,373
$39.30Price
1,867Shares
−13%Stake
What NTLA did after the filing
- The stock from Mon, Jul 10 close, $42.90
- −11.8%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Aug 21 close.
Traded Thu, Jul 6. Filed Mon, Jul 10, 1:21 PM ET, during the session. Returns use the Jul 10 close and the Aug 21 close. Not investment advice.